SUBSCRIBE
SUBSCRIBE
News   Business   Deals

Bristol-Myers Squibb Company Submits Letter to ImClone Systems Incorporated Board of Directors

September 11, 2008 | 
1 min read
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) submitted the following letter to ImClone Systems Incorporated (NASDAQ: IMCL) Board of Directors today:
Mergers & acquisitions
Bristol Myers Squibb Company
MORE ON THIS TOPIC
Creative poster collage of two business partners having deal financial payment giving money banknote isolated on beige color background.
Manufacturing
Samsung Biologics inks $262M manufacturing deal with European pharma company
September 11, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Words IPO (Initial public offering) with the trading data on the background.
IPO
2026 IPO stock tracker: How newly public biotechs are performing
September 9, 2026
 · 
1 min read
 · 
Gabrielle Masson
Metaphor of behavior of people crowd or butterfly effect or swarming of people or teamwork
IPO
Steady stream of crossover rounds stock biotech’s IPO pipeline
September 9, 2026
 · 
7 min read
 · 
Annalee Armstrong
Yellow road That has bright light at the destination, 3D Render.
Deals
Biotech is back, with H1 progress smoothing glide path through end of year: Truist
September 4, 2026
 · 
3 min read
 · 
Annalee Armstrong